Plain-English translation of NCT04595422 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether tobacco quitlines—the helplines that help people quit smoking—can be a good place to teach smokers about lung cancer screening. Researchers are training quitline staff to share information about screening with smokers who call for help, and they're asking those smokers to answer a few short questions to see if the information was helpful.
Many smokers and former smokers who are at risk for lung cancer don't know that screening is available, or they don't have good information about it. This study tests whether quitlines—which already talk to thousands of smokers—could be a simple way to reach people with this important health information.
You likely qualify if…
You likely don't qualify if…
If you're a smoker calling a quitline for help quitting, you'll be referred to educational materials about lung cancer screening. You'll then answer brief questionnaires about what you learned—one week after receiving the materials and again at 6 months. The whole process takes just a few minutes of your time beyond the regular quitline call.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States
Sponsor
M.D. Anderson Cancer Center
Collaborators
National Cancer Institute (NCI)
Enrollment target
~800 participants
Started
July 2020
Primary completion
October 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Robert J. Volk
M.D. Anderson Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.